camostat has been researched along with allylglycine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otsuki, M; Shirohara, H; Yamamoto, M | 1 |
| Hiwasa, T; Kondo, K; Nakagawara, A; Ohkoshi, M | 1 |
| Funakoshi, A; Kanai, S; Kawanami, T; Miyasaka, K; Shimazoe, T; Suzuki, S; Takata, Y; Watanabe, S; Yoshida, Y | 1 |
| Dagvadorj, J; Hiwasa, T; Iftakhar-E-Khuda, I; Koide, N; Komatsu, T; Naiki, Y; Ookoshi, M; Tumurkhuu, G; Yokochi, T; Yoshida, T | 1 |
4 other study(ies) available for camostat and allylglycine
| Article | Year |
|---|---|
CCK-, secretin-, and cholinergic-independent pancreatic fluid hypersecretion in protease inhibitor-treated rats.
Topics: Acetylcholine; Allylglycine; Animals; Benzamidines; Bicarbonates; Cell Division; Chlorides; Cholecystokinin; Esters; Gabexate; Guanidines; Male; Pancreas; Protease Inhibitors; Rats; Rats, Wistar; Secretin; Serine Proteinase Inhibitors | 1998 |
Potent growth-suppressive activity of a serine protease inhibitor, ONO-3403, toward malignant human neuroblastoma cell lines.
Topics: Allylglycine; Benzamidines; Cell Survival; Drug Screening Assays, Antitumor; Esters; Gabexate; Guanidines; Humans; Neuroblastoma; Protease Inhibitors; Serine Proteinase Inhibitors; Tumor Cells, Cultured | 1998 |
Different effects of trypsin inhibitors on intestinal gene expression of secretin and on pancreatic bicarbonate secretion in CCK-A-receptor-deficient rats.
Topics: Allylglycine; Animals; Benzamidines; Bicarbonates; Blotting, Northern; Body Weight; Cholecystokinin; Eating; Esters; Gabexate; Gene Expression Regulation; Guanidines; Intestinal Mucosa; Intestines; Pancreas; Pancreatic Juice; Rats; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; RNA, Messenger; Secretin; Trypsin Inhibitor, Kunitz Soybean; Trypsin Inhibitors | 1999 |
ONO 3403, a synthetic serine protease inhibitor, inhibits lipopolysaccharide-induced tumor necrosis factor-{alpha} and nitric oxide production and protects mice from lethal endotoxic shock.
Topics: Allylglycine; Animals; Benzamidines; Cell Line, Tumor; Culture Media, Conditioned; Esters; Female; Gabexate; Gene Expression; Guanidines; I-kappa B Proteins; Interferon Regulatory Factor-3; Interferon-gamma; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Liver; Macrophages; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Myeloid Differentiation Factor 88; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type II; Phosphorylation; Serine Proteases; Serine Proteinase Inhibitors; Shock, Septic; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2011 |